VivoSim Labs, Inc. Loss Contingency Accrual, Product Liability, Net
VivoSim Labs, Inc. (VIVS) had Loss Contingency Accrual, Product Liability, Net of $200.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyAccrualProductLiabilityNet · last filed 2026-08-12
- 2026-06-30: Loss Contingency Accrual, Product Liability, Net $200.00K.
- 2026-03-31: Loss Contingency Accrual, Product Liability, Net $200.00K.
- 2025-12-31: Loss Contingency Accrual, Product Liability, Net $200.00K.
- 2025-09-30: Loss Contingency Accrual, Product Liability, Net $200.00K.
| Period end | Loss Contingency Accrual, Product Liability, Net |
|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $200.00K 10-K · filed 2026-07-14 |
| 2025-12-31 | $200.00K 10-Q · filed 2026-02-11 |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $200.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $200.00K 10-K · filed 2025-06-05 |
| 2024-12-31 | $200.00K 10-Q · filed 2025-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |